Ichor Medical Systems Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Ichor Medical Systems Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014176
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ichor Medical Systems Inc (Ichor) is a medical equipment company that commercializes electroporation technology for the delivery of vaccines and DNA drugs. The company electroporation technology is used for the treatment and prevention of debilitating diseases. Its trigrid provides DNA drugs and vaccines for melanoma, malaria, hepatitis B virus (HBV) infection, human immunodeficiency virus (HIV) infection, influenza, and for other disease. Ichor’s proprietary platform, TriGrid delivery system uses electrical fields to enhance DNA drug delivery capability by up to thousand fold compared to conventional injection. The company also offers clinical trials for developing products to treat diseases such as HIV, melanoma, malaria, HBV, hemorrhagic fever with renal syndrome, cervical intraepithelial neoplasia, venezuelan equine encephalitis virus, breast cancer, and others. Ichor is headquartered in San Diego, California, the US.

Ichor Medical Systems Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Ichor Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ichor Medical Systems Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ichor Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ichor Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Ichor Medical Systems Inc, Medical Devices Deals, 2011 to YTD 2017 9
Ichor Medical Systems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ichor Medical Systems Inc, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
Ichor Medical Systems Enters Into Licensing Agreement With Pfizer 11
FIT Biotech Enters into Research Agreement with Ichor Medical Systems 12
Licensing Agreements 13
Ichor Medical Systems Enters into Licensing Agreement with Janssen Pharma 13
Ichor Medical Systems Inc – Key Competitors 14
Ichor Medical Systems Inc – Key Employees 15
Ichor Medical Systems Inc – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Ichor Medical Systems Inc, Pharmaceuticals & Healthcare, Key Facts 2
Ichor Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Ichor Medical Systems Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Ichor Medical Systems Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Ichor Medical Systems Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Ichor Medical Systems Inc, Medical Devices Deals, 2011 to YTD 2017 9
Ichor Medical Systems Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Ichor Medical Systems Enters Into Licensing Agreement With Pfizer 11
FIT Biotech Enters into Research Agreement with Ichor Medical Systems 12
Ichor Medical Systems Enters into Licensing Agreement with Janssen Pharma 13
Ichor Medical Systems Inc, Key Competitors 14
Ichor Medical Systems Inc, Key Employees 15

★海外企業調査レポート[Ichor Medical Systems Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Celldex Therapeutics, Inc.:企業のM&A・事業提携・投資動向
    Celldex Therapeutics, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Celldex Therapeutics, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • HNZ Group Inc.:戦略・SWOT・企業財務分析
    HNZ Group Inc. - Strategy, SWOT and Corporate Finance Report Summary HNZ Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Forward Industries, Inc. (FORD):企業の財務・戦略的SWOT分析
    Forward Industries, Inc. (FORD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • J.L.Clark, Inc.:企業の戦略的SWOT分析
    J.L.Clark, Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Walton Electric Membership Corporation:企業の発電所・SWOT分析2018
    Walton Electric Membership Corporation - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, informati …
  • Range Resources Corp (RRC)-石油・ガス分野:企業M&A・提携分析
    Summary Range Resources Corp (Range) is independent oil, natural gas and natural gas liquids (NGL) company that explores, develops, and acquires natural gas and oil properties in the US. It has oil and gas properties in the Appalachian basin and Northern Louisiana of the US. Range’s natural gas and …
  • Telephonics Corporation:企業の戦略的SWOT分析
    Telephonics Corporation - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • Abivax SA (ABVX)-製薬・医療分野:企業M&A・提携分析
    Summary Abivax SA (Abivax) is a biotechnology company that researches, develops and commercializes anti-viral therapies and therapeutic vaccines for the treatment of infectious diseases. The company’s pipeline products comprise ABX464, a small molecule against HIV; ABX311 for chikungunya; ABX544 to …
  • CHC Group LLC:企業の戦略的SWOT分析
    CHC Group LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Ennis, Inc. (EBF):企業の財務・戦略的SWOT分析
    Ennis, Inc. (EBF) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • NETGEAR, Inc.:企業の戦略・SWOT・財務情報
    NETGEAR, Inc. - Strategy, SWOT and Corporate Finance Report Summary NETGEAR, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Nanomerics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Nanomerics Ltd (Nanomerics) is a healthcare solution provider that develops drug delivery solutions for poorly water soluble drugs, nucleic acids and peptides. The company offers products such as METDoloron, METSporine, METAmphizon, METEnkalon, MET undisclosed, MET ocular undiscl, ocular und …
  • Logicor Europe Ltd:企業の戦略的SWOT分析
    Logicor Europe Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • Arno Therapeutics Inc (ARNI)-医療機器分野:企業M&A・提携分析
    Summary Arno Therapeutics Inc (Arno) is a clinical stage biopharmaceutical company that develops products for the treatment of cancer, infectious diseases and other life threatening diseases. The company has exclusive worldwide rights for the development and commercialization of Onapristone (for the …
  • Torii Pharmaceutical Co Ltd (4551)-製薬・医療分野:企業M&A・提携分析
    Summary Torii Pharmaceutical Co Ltd (Torii) a subsidiary of Japan Tobacco Inc is a healthcare product provider that manufactures and markets products such as antebate ointment, antebate cream and urinorm used for the treatment of hyperuricemia and gout. The company offers products for the treatment …
  • E-CO Energi Holding AS-エネルギー分野:企業M&A・提携分析
    Summary E-CO Energi Holding AS (E-CO Energi) owned by the City of Oslo is an energy company. It owns, operates and develops hydroelectric plants. The company is the second largest hydropower producer in Norway. E-CO Energi also carries out the business development in energy and related fields. The c …
  • Artes Biotechnology GmbH-製薬・医療分野:企業M&A・提携分析
    Summary Artes Biotechnology GmbH (ARTES) is a developer of recombinant production cell lines and processes that is based on the microbial expression platforms. The company offers biosimilars, enzymes and proteins and vaccines. It offers technology transfer and implementation support, protein analyti …
  • AnaBios Corp:製薬・医療:M&Aディール及び事業提携情報
    Summary AnaBios Corp (AnaBios) is a pre-clinical stage contract research organization that offers drug efficacy studies on human samples. The organization’s products portfolio includes human dorsal root ganglia neuron cultures, human cardiac mesenchymal stem cells, human heart tissue samples, human …
  • Ultra Petroleum Corp.:企業の戦略・SWOT・財務分析
    Ultra Petroleum Corp. - Strategy, SWOT and Corporate Finance Report Summary Ultra Petroleum Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Alector LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Alector LLC (Alector) is a biotechnology company that develops therapies for immune system to cure neurodegeneration and cancer. The company discovers and develops immune modulatory therapies for Alzheimer’s disease and other neurodegenerative disorders. It combines state-of-the-art antibody …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆